Log in to save to my catalogue

Inducing and exploiting vulnerabilities for the treatment of liver cancer

Inducing and exploiting vulnerabilities for the treatment of liver cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6858884

Inducing and exploiting vulnerabilities for the treatment of liver cancer

About this item

Full title

Inducing and exploiting vulnerabilities for the treatment of liver cancer

Publisher

London: Nature Publishing Group UK

Journal title

Nature (London), 2019-10, Vol.574 (7777), p.268-272

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Liver cancer remains difficult to treat, owing to a paucity of drugs that target critical dependencies
1
,
2
; broad-spectrum kinase inhibitors such as sorafenib provide only a modest benefit to patients with hepatocellular carcinoma
3
. The induction of senescence may represent a strategy for the treatment of cancer, especially w...

Alternative Titles

Full title

Inducing and exploiting vulnerabilities for the treatment of liver cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6858884

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6858884

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/s41586-019-1607-3

How to access this item